These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5027100)

  • 21. [EFFECTS OF LOCAL AND SYSTEMIC CATECHOLAMINE INJECTIONS ON THE EXCITABILITY OF THE DIENCEPHALIC AND BULBAR VASOMOTOR CENTERS].
    SCHMITT H; SCHMITT H
    Arch Int Pharmacodyn Ther; 1964 Aug; 150():306-21. PubMed ID: 14203110
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of disulfiram on the restoration of the response to tyramine by dopamine and alpha-methyl-dopa in the reserpine-treated cat.
    Musacchio JM; Bhagat B; Jackson CJ; Kopin IJ
    J Pharmacol Exp Ther; 1966 May; 152(2):293-7. PubMed ID: 5944371
    [No Abstract]   [Full Text] [Related]  

  • 23. Demonstration by the histochemical fluorescence method of the prolonged disappearance of catecholamines from the denervated nictitating membrane of the cat.
    Weiner N; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1967 Aug; 157(2):284-9. PubMed ID: 6039820
    [No Abstract]   [Full Text] [Related]  

  • 24. Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization.
    Langer SZ; Draskóczy PR; Trendelenburg U
    J Pharmacol Exp Ther; 1967 Aug; 157(2):255-73. PubMed ID: 6039818
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of electrical stimulation, -methyltyrosine and desmethylimipramine on the norepinephrine contents of neuronal cell bodies and terminals.
    Bhatnagar RK; Moore KE
    J Pharmacol Exp Ther; 1971 Sep; 178(3):450-63. PubMed ID: 5571897
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of reserpine on the responses of the nictitating membrane in the cat.
    NAKAMURA K; SHIMAMOTO K
    Jpn J Pharmacol; 1960 Mar; 9():150-8. PubMed ID: 13727613
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of metanephrine on responses of the nictitating membrane of the pithed cat to sympathomimetic amines.
    Langer SZ; Bogaert MG; De Schaepdryver AF
    J Pharmacol Exp Ther; 1967 Sep; 157(3):517-23. PubMed ID: 6048012
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of reserpine pretreatment on the D- and L-isomers of some sympathomimetic amines.
    Patil PN; Tye A; LaPidus JB
    J Pharmacol Exp Ther; 1965 Aug; 149(2):199-205. PubMed ID: 5318936
    [No Abstract]   [Full Text] [Related]  

  • 29. Adrenergic nerve function, noradrenaline level and noradrenaline uptake in cat nictitating membrane after reserpine treatment.
    Andén NE; Henning M
    Acta Physiol Scand; 1966; 67(3):498-504. PubMed ID: 5967610
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and biochemical effects of chronic reserpine administration in mongrel dogs.
    Adams HR; Dixit BN; Smookler HH; Buckley JP
    Am J Vet Res; 1972 Apr; 33(4):699-707. PubMed ID: 5017867
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of beta-TM 10 on the pharmacological, biochemical and morphological changes induced by denervation of the nictitating membrane in the cat.
    Pluchino S; Van Orden LS; Draskóczy PR; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1970 Mar; 172(1):77-90. PubMed ID: 5416947
    [No Abstract]   [Full Text] [Related]  

  • 32. Supersensitivity of the nictitating membrane to 5-hydroxytryptamine and norepinephrine after various procedures.
    Wakade AR; Kanwar RS; Gulati OD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):189-96. PubMed ID: 5471446
    [No Abstract]   [Full Text] [Related]  

  • 33. Some direct and indirect sympathomimetic actions of metaraminol.
    Stone CA; Stavorski JM; Ludden CT; Wenger HC; Torchiana ML
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):49-60. PubMed ID: 5941882
    [No Abstract]   [Full Text] [Related]  

  • 34. Centrally mediated cardiovascular effects of angiotensin II.
    Smookler HH; Severs WB; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 Sep; 153(3):485-94. PubMed ID: 4288411
    [No Abstract]   [Full Text] [Related]  

  • 35. [Normetanephrine and contractions of the nictitating membranes in reserpine-treated cats].
    BACQ ZM; DRESSE A
    C R Seances Soc Biol Fil; 1961; 155():1170-2. PubMed ID: 13863795
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the decentralized nictitating membrane of the cat. I. Effect of postganglionic electrical stimulation on the response to exogenous catecholamines.
    Cervoni P; Kirpekar SM
    J Pharmacol Exp Ther; 1966 Apr; 152(1):8-17. PubMed ID: 5937405
    [No Abstract]   [Full Text] [Related]  

  • 37. Contraction of cat nictitating membrane by tetramisole.
    Dhume VG; Pereira JS; Diniz RS; Abraham GJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):14-8. PubMed ID: 485698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat.
    Green RD; Fleming WW
    J Pharmacol Exp Ther; 1967 May; 156(2):207-14. PubMed ID: 6026252
    [No Abstract]   [Full Text] [Related]  

  • 39. The density of adrenergic innervation of the cat's nictitating membrane as a factor influencing the sensitivity of the isolated preparation to l-norepinephrine.
    Trendelenburg U; Draskóczy PR; Pluchino S
    J Pharmacol Exp Ther; 1969 Mar; 166(1):14-25. PubMed ID: 5776018
    [No Abstract]   [Full Text] [Related]  

  • 40. TIME COURSE OF CHANGES IN SENSITIVITY AFTER DENERVATION OF THE NICTITATING MEMBRANE OF THE SPINAL CAT.
    TRENDELENBURG U
    J Pharmacol Exp Ther; 1963 Dec; 142():335-42. PubMed ID: 14098330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.